{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:11:24Z","timestamp":1790395884616,"version":"4.1.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["FKZ 01ZX1314H"],"award-info":[{"award-number":["FKZ 01ZX1314H"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004189","name":"Max-Planck-Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005363","name":"Universidad de Buenos Aires","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.molmed.2018.07.005","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T17:52:57Z","timestamp":1533577977000},"page":"736-747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["P2X7 Receptor: A Potential Therapeutic Target for Depression?"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9329-5252","authenticated-orcid":false,"given":"Jan M.","family":"Deussing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Arzt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2018.07.005_bib0005","series-title":"Depression and Other Common Mental Disorders: Global Health Estimates","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.molmed.2018.07.005_bib0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1176\/appi.ajp.163.1.109","article-title":"A Swedish national twin study of lifetime major depression","volume":"163","author":"Kendler","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.molmed.2018.07.005_bib0015","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrg3240","article-title":"Genetic architectures of psychiatric disorders: the emerging picture and its implications","volume":"13","author":"Sullivan","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.molmed.2018.07.005_bib0020","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3109\/10253890.2011.604879","article-title":"Effects of stress across the lifespan","volume":"14","author":"Koenig","year":"2011","journal-title":"Stress"},{"key":"10.1016\/j.molmed.2018.07.005_bib0025","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.2174\/138161209788168001","article-title":"Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today","volume":"15","author":"Lopez-Munoz","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.molmed.2018.07.005_bib0030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrn1683","article-title":"Stress and the brain: from adaptation to disease","volume":"6","author":"de Kloet","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.molmed.2018.07.005_bib0035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrn1846","article-title":"New approaches to antidepressant drug discovery: beyond monoamines","volume":"7","author":"Berton","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.molmed.2018.07.005_bib0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1570159X14666160309114549","article-title":"Molecular and cellular mechanisms of rapid-acting antidepressants ketamine and scopolamine","volume":"15","author":"Wohleb","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.molmed.2018.07.005_bib0045","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrn.2016.69","article-title":"Integrating neuroimmune systems in the neurobiology of depression","volume":"17","author":"Wohleb","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.molmed.2018.07.005_bib0050","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molmed.2018.07.005_bib0055","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2018.07.005_bib0060","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.molmed.2018.07.005_bib0065","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.molmed.2018.07.005_bib0070","first-page":"4195","article-title":"Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis","volume":"55","author":"Kohler","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.molmed.2018.07.005_bib0075","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1124\/pr.113.008144","article-title":"Neuroinflammation and comorbidity of pain and depression","volume":"66","author":"Walker","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.molmed.2018.07.005_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2008.01.004","article-title":"Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders","volume":"85","author":"Anisman","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.molmed.2018.07.005_bib0085","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2018.07.005_bib0090","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/mp.2017.188","article-title":"Purinergic system in psychiatric diseases","volume":"23","author":"Cheffer","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.molmed.2018.07.005_bib0095","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1093\/hmg\/ddl166","article-title":"P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder","volume":"15","author":"Lucae","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2018.07.005_bib0100","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/ajmg.b.30303","article-title":"Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder","volume":"141B","author":"Barden","year":"2006","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.molmed.2018.07.005_bib0105","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.272.5262.735","article-title":"The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7)","volume":"272","author":"Surprenant","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.molmed.2018.07.005_bib0110","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1476-5381.2009.00233.x","article-title":"Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors","volume":"157","author":"Donnelly-Roberts","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.molmed.2018.07.005_bib0115","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.22153","article-title":"Structural basis for subtype-specific inhibition of the P2X7 receptor","volume":"5","author":"Karasawa","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.molmed.2018.07.005_bib0120","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1038\/sj.emboj.7601378","article-title":"Pannexin-1 mediates large pore formation and interleukin-1\u03b2 release by the ATP-gated P2X7 receptor","volume":"25","author":"Pelegrin","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2018.07.005_bib0125","doi-asserted-by":"crossref","first-page":"8853","DOI":"10.1074\/jbc.M211094200","article-title":"P2X7 receptor cell surface expression and cytolytic pore formation are regulated by a distal C-terminal region","volume":"278","author":"Smart","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2018.07.005_bib0130","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31186","article-title":"The P2X7 receptor forms a dye-permeable pore independent of its intracellular domain but dependent on membrane lipid composition","volume":"6","author":"Karasawa","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.molmed.2018.07.005_bib0135","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.tcb.2018.01.005","article-title":"The elusive P2X7 macropore","volume":"28","author":"Di Virgilio","year":"2018","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.molmed.2018.07.005_bib0140","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1399-0039.2011.01780.x","article-title":"The human P2X7 receptor and its role in innate immunity","volume":"78","author":"Wiley","year":"2011","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.molmed.2018.07.005_bib0145","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fphar.2017.00123","article-title":"The P2X7 receptor\u2013interleukin-1 liaison","volume":"8","author":"Giuliani","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.molmed.2018.07.005_bib0150","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bcp.2017.12.021","article-title":"The P2X7 receptor: a main player in inflammation","volume":"151","author":"Adinolfi","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.molmed.2018.07.005_bib0155","first-page":"14","article-title":"Regulation of innate immunity by extracellular nucleotides","volume":"3","author":"Gorini","year":"2013","journal-title":"Am. J. Blood Res."},{"key":"10.1016\/j.molmed.2018.07.005_bib0160","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1017\/S1461145711001933","article-title":"The absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice","volume":"16","author":"Cs\u00f6lle","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.molmed.2018.07.005_bib0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066547","article-title":"Neurochemical changes in the mouse hippocampus underlying the antidepressant effect of genetic deletion of P2X7 receptors","volume":"8","author":"Cs\u00f6lle","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2018.07.005_bib0170","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neuropharm.2013.05.017","article-title":"P2X7 receptors at adult neural progenitor cells of the mouse subventricular zone","volume":"73","author":"Messemer","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.molmed.2018.07.005_bib0175","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neuroscience.2011.05.049","article-title":"Resilience and reduced c-Fos expression in P2X7 receptor knockout mice exposed to repeated forced swim test","volume":"189","author":"Boucher","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.molmed.2018.07.005_bib0180","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bbi.2014.05.017","article-title":"Chronic stress induces prolonged suppression of the P2X7 receptor within multiple regions of the hippocampus: a cumulative threshold spectra analysis","volume":"42","author":"Kongsui","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.molmed.2018.07.005_bib0185","doi-asserted-by":"crossref","first-page":"7049","DOI":"10.1523\/JNEUROSCI.3103-16.2017","article-title":"Neuronal P2X7 receptors revisited: do they really exist?","volume":"37","author":"Illes","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2018.07.005_bib0190","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.1523\/JNEUROSCI.3104-16.2017","article-title":"Neuronal P2X7 receptor: involvement in neuronal physiology and pathology","volume":"37","author":"Miras-Portugal","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2018.07.005_bib0195","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tins.2006.03.003","article-title":"Emerging challenges of assigning P2X7 receptor function and immunoreactivity in neurons","volume":"29","author":"Anderson","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.molmed.2018.07.005_bib0200","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1523\/JNEUROSCI.1469-04.2004","article-title":"Reanalysis of P2X7 receptor expression in rodent brain","volume":"24","author":"Sim","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2018.07.005_bib0205","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/sj.mp.4001601","article-title":"A genome-wide scan points to a susceptibility locus for bipolar disorder on chromosome 12","volume":"10","author":"Shink","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.molmed.2018.07.005_bib0210","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/mp.2008.6","article-title":"Case-control studies show that a non-conservative amino-acid change from a glutamine to arginine in the P2RX7 purinergic receptor protein is associated with both bipolar- and unipolar-affective disorders","volume":"14","author":"McQuillin","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.molmed.2018.07.005_bib0215","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ajmg.b.31179","article-title":"P2RX7 gene is associated consistently with mood disorders and predicts clinical outcome in three clinical cohorts","volume":"156B","author":"Soronen","year":"2011","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.molmed.2018.07.005_bib0220","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pnpbp.2017.11.003","article-title":"The P2RX7 polymorphism rs2230912 is associated with depression: a meta-analysis","volume":"82","author":"Czamara","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2018.07.005_bib0225","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/ajmg.b.30931","article-title":"P2RX7: a bipolar and unipolar disorder candidate susceptibility gene?","volume":"150B","author":"Green","year":"2009","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.molmed.2018.07.005_bib0230","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ajmg.b.30799","article-title":"Association between depression and the Gln460Arg polymorphism of P2RX7 gene: a dimensional approach","volume":"150B","author":"Hejjas","year":"2009","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.molmed.2018.07.005_bib0235","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/ajmg.b.30952","article-title":"Variation in P2RX7 candidate gene (rs2230912) is not associated with bipolar I disorder and unipolar major depression in four European samples","volume":"150B","author":"Grigoroiu-Serbanescu","year":"2009","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.molmed.2018.07.005_bib0240","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jad.2008.12.021","article-title":"Case-control association study of 65 candidate genes revealed a possible association of a SNP of HTR5A to be a factor susceptible to bipolar disease in Bulgarian population","volume":"117","author":"Yosifova","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.molmed.2018.07.005_bib0245","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jad.2010.02.113","article-title":"Variations in FKBP5 and BDNF genes are suggestively associated with depression in a Swedish population-based cohort","volume":"125","author":"Lavebratt","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.molmed.2018.07.005_bib0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043057","article-title":"P2RX7: expression responds to sleep deprivation and associates with rapid cycling in bipolar disorder type 1","volume":"7","author":"Backlund","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2018.07.005_bib0255","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jad.2013.02.033","article-title":"Associations between depression severity and purinergic receptor P2RX7 gene polymorphisms","volume":"150","author":"Halmai","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.molmed.2018.07.005_bib0260","article-title":"Lack of association of P2RX7 gene rs2230912 polymorphism with mood disorders: a meta-analysis","volume":"9","author":"Feng","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2018.07.005_bib0265","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jpsychires.2010.04.013","article-title":"Functional significance of P2RX7 polymorphisms associated with affective mood disorders","volume":"44","author":"Sluyter","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.molmed.2018.07.005_bib0270","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1096\/fj.09-150862","article-title":"Two haplotypes of the P2X7 receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of-function effect and enhanced interleukin-1\u03b2 secretion","volume":"24","author":"Stokes","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.molmed.2018.07.005_bib0275","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/ejhg.2011.253","article-title":"Single-nucleotide polymorphisms in the P2X7 receptor gene are associated with post-menopausal bone loss and vertebral fractures","volume":"20","author":"J\u00f8rgensen","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2018.07.005_bib0280","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jpsychires.2009.10.005","article-title":"Single nucleotide polymorphisms that were identified in affective mood disorders affect ATP-activated P2X7 receptor functions","volume":"44","author":"Roger","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.molmed.2018.07.005_bib0285","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11302-016-9546-z","article-title":"Genetically dissecting P2rx7 expression within the central nervous system using conditional humanized mice","volume":"13","author":"Metzger","year":"2017","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.molmed.2018.07.005_bib0290","doi-asserted-by":"crossref","first-page":"11688","DOI":"10.1523\/JNEUROSCI.3487-16.2017","article-title":"Heterozygosity for the mood disorder-associated variant Gln460Arg alters P2X7 receptor function and sleep quality","volume":"37","author":"Metzger","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2018.07.005_bib0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151862","article-title":"Co-expression of wild-type P2X7R with Gln460Arg variant alters receptor function","volume":"11","author":"Aprile-Garcia","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2018.07.005_bib0300","doi-asserted-by":"crossref","first-page":"17228","DOI":"10.1074\/jbc.M602999200","article-title":"A truncated P2X7 receptor variant (P2X7-j) endogenously expressed in cervical cancer cells antagonizes the full-length P2X7 receptor through hetero-oligomerization","volume":"281","author":"Feng","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2018.07.005_bib0305","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1096\/fj.09-153601","article-title":"Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor","volume":"24","author":"Adinolfi","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.molmed.2018.07.005_bib0310","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11302-011-9215-1","article-title":"C terminus of the P2X7 receptor: treasure hunting","volume":"7","author":"Costa-Junior","year":"2011","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.molmed.2018.07.005_bib0315","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00441-013-1708-5","article-title":"Targeted mutagenesis tools for modelling psychiatric disorders","volume":"354","author":"Deussing","year":"2013","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.molmed.2018.07.005_bib0320","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1074\/jbc.M006781200","article-title":"Altered cytokine production in mice lacking P2X7 receptors","volume":"276","author":"Solle","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2018.07.005_bib0325","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pain.2005.01.002","article-title":"Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain","volume":"114","author":"Chessell","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.molmed.2018.07.005_bib0330","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bbr.2008.10.018","article-title":"Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders","volume":"198","author":"Basso","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.molmed.2018.07.005_bib0335","doi-asserted-by":"crossref","first-page":"25813","DOI":"10.1074\/jbc.M109.033134","article-title":"A functional P2X7 splice variant with an alternative transmembrane domain 1 escapes gene inactivation in P2X7 knock-out mice","volume":"284","author":"Nicke","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2018.07.005_bib0340","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1189\/jlb.0408251","article-title":"Lymphocytes from P2X7-deficient mice exhibit enhanced P2X7 responses","volume":"85","author":"Taylor","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.molmed.2018.07.005_bib0345","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1021\/cn500054n","article-title":"The first CNS-active carborane: a novel P2X7 receptor antagonist with antidepressant activity","volume":"5","author":"Wilkinson","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.molmed.2018.07.005_bib0350","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biopsych.2015.11.026","article-title":"Psychological stress activates the inflammasome via release of adenosine triphosphate and stimulation of the purinergic type 2X7 receptor","volume":"80","author":"Iwata","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2018.07.005_bib0355","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12974-017-0865-y","article-title":"Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors","volume":"14","author":"Yue","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.molmed.2018.07.005_bib0360","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S0140-6736(13)60855-7","article-title":"Genetics of bipolar disorder","volume":"381","author":"Craddock","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2018.07.005_bib0365","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41588-018-0090-3","article-title":"Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression","volume":"50","author":"Wray","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2018.07.005_bib0370","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1038\/ncomms4339","article-title":"Genome-wide association study reveals two new risk loci for bipolar disorder","volume":"5","author":"Muhleisen","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2018.07.005_bib0375","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fpsyt.2014.00048","article-title":"Gene\u2013environment interactions in severe mental illness","volume":"5","author":"Uher","year":"2014","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.molmed.2018.07.005_bib0380","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/ng.2711","article-title":"Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs","volume":"45","author":"Lee","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2018.07.005_bib0385","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1017\/S0033291715002172","article-title":"Polygenic interactions with environmental adversity in the aetiology of major depressive disorder","volume":"46","author":"Mullins","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.molmed.2018.07.005_bib0390","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1038\/s41598-018-22221-z","article-title":"Significance of risk polymorphisms for depression depends on stress exposure","volume":"8","author":"Gonda","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2018.07.005_bib0395","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/nn.4113","article-title":"Neuroimmune mechanisms of depression","volume":"18","author":"Hodes","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.molmed.2018.07.005_bib0400","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jpsychires.2009.08.013","article-title":"Wake and sleep EEG provide biomarkers in depression","volume":"44","author":"Steiger","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.molmed.2018.07.005_bib0405","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hup.964","article-title":"Circadian rhythm disturbances in depression","volume":"23","author":"Germain","year":"2008","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.molmed.2018.07.005_bib0410","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s11920-007-0065-z","article-title":"Rapid eye movement (REM) sleep: an endophenotype for depression","volume":"9","author":"Modell","year":"2007","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.molmed.2018.07.005_bib0415","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1152\/japplphysiol.00586.2010","article-title":"ATP and the purine type 2X7 receptor affect sleep","volume":"109","author":"Krueger","year":"2010","journal-title":"J. Appl. Physiol. (1985)"},{"key":"10.1016\/j.molmed.2018.07.005_bib0420","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fncel.2015.00258","article-title":"Understanding the role of P2X7 in affective disorders \u2013 are glial cells the major players?","volume":"9","author":"Stokes","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.molmed.2018.07.005_bib0425","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.tips.2014.08.002","article-title":"P2X7 receptor: an emerging target in central nervous system diseases","volume":"35","author":"Sperlagh","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.molmed.2018.07.005_bib0430","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/glia.23001","article-title":"The microglial ATP-gated ion channel P2X7 as a CNS drug target","volume":"64","author":"Bhattacharya","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.molmed.2018.07.005_bib0435","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3899\/jrheum.110874","article-title":"Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate","volume":"39","author":"Stock","year":"2017","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.molmed.2018.07.005_bib0440","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1136\/annrheumdis-2011-143578","article-title":"Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine","volume":"71","author":"Keystone","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molmed.2018.07.005_bib0445","first-page":"2247","article-title":"Safety and efficacy of an oral inhibitor of the purinergic receptor P2X7 in adult patients with moderately to severely active Crohn\u2019s disease: a randomized placebo-controlled, double-blind, Phase IIa study","volume":"221","author":"Eser","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.molmed.2018.07.005_bib0450","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fphar.2018.00030","article-title":"Recent advances in CNS P2X7 physiology and pharmacology: focus on neuropsychiatric disorders","volume":"9","author":"Bhattacharya","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.molmed.2018.07.005_bib0455","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2017.12.006","article-title":"Synthesis and in vitro characterization of a P2X7 radioligand [123I]TZ6019 and its response to neuroinflammation in a mouse model of Alzheimer disease","volume":"820","author":"Jin","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.molmed.2018.07.005_bib0460","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1096\/fj.11-196089","article-title":"Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice","volume":"26","author":"Engel","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.molmed.2018.07.005_bib0465","doi-asserted-by":"crossref","first-page":"44628","DOI":"10.1074\/jbc.M112.390971","article-title":"The specificity protein factor Sp1 mediates transcriptional regulation of P2X7 receptors in the nervous system","volume":"287","author":"Garcia-Huerta","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2018.07.005_bib0470","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1523\/JNEUROSCI.4218-14.2015","article-title":"Astrocyte-mediated ischemic tolerance","volume":"35","author":"Hirayama","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2018.07.005_bib0475","doi-asserted-by":"crossref","DOI":"10.1038\/srep17486","article-title":"MicroRNA targeting of the P2X7 purinoceptor opposes a contralateral epileptogenic focus in the hippocampus","volume":"5","author":"Jimenez-Mateos","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2018.07.005_bib0480","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1210\/en.2015-1673","article-title":"Diversity of reporter expression patterns in transgenic mouse lines targeting corticotropin-releasing hormone-expressing neurons","volume":"156","author":"Chen","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmed.2018.07.005_bib0485","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.neuron.2014.12.036","article-title":"Diversity of transgenic mouse models for selective targeting of midbrain dopamine neurons","volume":"85","author":"Lammel","year":"2015","journal-title":"Neuron"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491418301448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491418301448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:15:35Z","timestamp":1761462935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491418301448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":97,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1471491418301448"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2018.07.005","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P2X7 Receptor: A Potential Therapeutic Target for Depression?","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2018.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}